Variables | Control group (N = 30) | Mild persistent (N = 34) | Moderate persistent (N = 26) | Severe persistent (N = 10) | ANOVA | P |
---|---|---|---|---|---|---|
Mean ± SD | Mean ± SD | Mean ± SD | Mean ± SD | |||
Age (years) | 10.7 ± 3.3 | 10.4 ± 3.2 | 11 ± 3.2 | 9.8 ± 2.4 | 0.417 | 0.741 |
Sex | Â | Â | Â | Â | Â | Â |
Male N (%) | 15 (50%) | 20 (58.8%) | 10 (38.5%) | 6 (60%) | χ2 = 2.8 | 0.419 |
Female N (%) | 15 (50%) | 14 (41.2%) | 16 (61.5%) | 4 (40%) | Â | Â |
Eosinophils cells × 109/L | 213.5 ± 54.4 | 251.6 ± 87.0 | 412.4 ± 34.1 | 549.8 ± 44.2 | 96.6 | < 0.001* |
Serum IgE IU\mL | 156.3 ± 34.6 | 482.8 ± 120.3 | 733.8 ± 147.8 | 1019.4 ± 137.0 | 119.4 | < 0.001* |
FEV1\ FVC | 89.4 ± 1.44 | 87.5 ± 4.02 | 78.4 ± 2.89 | 65. 3 ± 7.75 | 184.4 | < 0.001* |
FEV1% | 95.05 ± 2.09 | 84.4 ± 1.56 | 70.2 ± 4.14 | 52.0 ± 6.51 | 352.9 | < 0.001* |
FVC% | 92.7 ± 2.51 | 88.0 ± 4.75 | 72.3 ± 5.00 | 55.5 ± 7.20 | 43.1 | < 0.001* |